| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/25/2006 | CN1723913A Method for preparing coenzyme-A sublingual lozenge |
| 01/25/2006 | CN1238379C New osteoclast formation inhibiting factor and its coding sequence and use |
| 01/25/2006 | CN1238363C Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 01/25/2006 | CN1238347C Heterocyclic derivatives |
| 01/25/2006 | CN1238055C Medicine for curing metabolic syndrome |
| 01/25/2006 | CN1237990C Capsules for reducing fat and its production technique |
| 01/25/2006 | CN1237982C Cactus primary juice and its preparation method and application |
| 01/25/2006 | CN1237974C Ursolic acid dripping pills and its preparation process |
| 01/25/2006 | CN1237961C Use of diphenyl ethylene-like compounds in preparing medicaments for treating and preventing diabetes or diseases associated with retrovirus |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989382 Enzyme inhibitors; pyridin-2-yl-amino-ethyl-amino-phenyl derivatives; diabetes, Alzheimer's disease, Parkinson's disease, Huntington's disease, obesity, cardiovascular disease, hypertension, polycystic ovary syndrome, ischemia, brain injury |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989366 Exendins, exendin agonists, and methods for their use |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989166 Soft drink replacer |
| 01/24/2006 | US6989165 Synergistic composition for treating hyperilipdemia |
| 01/24/2006 | US6989148 Treatment of diabetes |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/24/2006 | CA2352392C Eletriptan hydrobromide monohydrate |
| 01/24/2006 | CA2347117C Methods for inhibiting diabetic complications |
| 01/24/2006 | CA2138127C New acyclic amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compounds |
| 01/19/2006 | WO2006005667A2 Polypeptide protracting tags comprising a tetrazole moiety |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | US20060015951 Proteins involved in the regulation of energy homeostasis |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014953 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014788 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014784 Compounds for the treatment of metabolic disorders |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014766 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors |
| 01/19/2006 | US20060014762 2-Pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 01/19/2006 | US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014679 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 01/19/2006 | US20060014678 adminsteration of Peptide YY and glucagons-like peptide-1( GLP-1) or agonists to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014241 Extended glucagon-like peptide-1 analogs |
| 01/19/2006 | US20060013901 Compositions comprising flavonoids and tocotrienols and methods thereof |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013861 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 01/19/2006 | US20060013775 Use of ppar activators for the treatment of pulmonary fibrosis |
| 01/19/2006 | DE102004032263A1 New 7-butynyl-8-(3-amino-1-piperidinyl)xanthine derivatives useful as dipeptidyl peptidase IV inhibitors, e.g. for treating diabetes, arthritis, obesity and osteoporosis |
| 01/19/2006 | CA2573603A1 Novel 2,4-diaminothiazol-5-one derivatives |
| 01/19/2006 | CA2573261A1 Compositions for enhancing the production of ppar and/or ppar-associated factors |
| 01/19/2006 | CA2573209A1 Combination of dpp-iv inhibitors and compounds modulating 5-ht3 and/or 5-ht4 receptors |
| 01/19/2006 | CA2572815A1 Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
| 01/19/2006 | CA2572770A1 Polypeptide protracting tags comprising a tetrazole moiety |
| 01/19/2006 | CA2570518A1 Tetracyclic compounds as estrogen ligands |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616960A2 Human pancreatic cell lines: developments and uses |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616873A1 Lipid-regulating agent and use thereof |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616856A1 Novel transcriptional factor, process for producing the same and use thereof |
| 01/18/2006 | EP1616576A1 Specific nad(p)h oxidase inhibitor |
| 01/18/2006 | EP1616561A1 Antidiabetic preparation for oral administration |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615925A1 Imidazopyridine derivatives as melanocortin receptor agonists |
| 01/18/2006 | EP1615900A1 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
| 01/18/2006 | EP1615887A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 01/18/2006 | EP1615884A1 Process for the preparation of amorphous calcium salt of atorvastatin |
| 01/18/2006 | EP1615698A2 New amide derivatives and pharmaceutical use thereof |
| 01/18/2006 | EP1615697A2 New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof |
| 01/18/2006 | EP1615666A2 Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
| 01/18/2006 | EP1615655A1 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/18/2006 | EP1615647A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/18/2006 | EP1615644A1 Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity |
| 01/18/2006 | EP1615637A1 Pharmaceutical use of substituted 1,2,4-triazoles |
| 01/18/2006 | EP1615630A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
| 01/18/2006 | EP1487427A4 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1219595B1 O-anisamide derivatives |
| 01/18/2006 | EP1212335B1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | EP1207161B1 Novel isoindole derivatives |
| 01/18/2006 | EP1169475B1 Diagnosis of a person's risk for developing diabetic retinopathy |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | EP0915910B1 Exendin analogues, processes for their preparation and medicaments containing them |
| 01/18/2006 | CN1723214A Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 01/18/2006 | CN1723212A Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |